NCT00857792View on ClinicalTrials.gov

Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Coronary Disease

Interventions

DRUG

regadenoson

Subjects will be given a single dose of regadenoson (0.4 mg, i.e. 5 ml i.v. bolus).

Trial Locations (1)

60637

University of Chicago, Chicago

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

University of Chicago

OTHER

NCT00857792 - Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging | Biotech Hunter | Biotech Hunter